tert-Butyl (3aR,6aR)-2-phenylhexahydropyrrolo[3,4-c]pyrrole-3a(1H)-carboxylate, 95%, 250mg

3,5-Dibromo-1-methylpyridin-2(1H)-one, 95.0%, 1g

1-Bromo-3,5-bis(methylthio)benzene, 98%, 500mg

Sal disódica de magnesio EDTA x H2O, mínimo 90%, para síntesis, 500 g, envase de plástico.

3-Bromo-2-nitropyridine, 98.0%, 100g

DL-Pyroglutamic Acid>99.0%(T)100g

1,3-Diphenyl-1,3-propanedione>98.0%(GC)25g

1H-pyrrolo[3,2-b]pyridin-6-amine hydrochloride, 95.0%, 250mg

N-(4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxamide, 98%, 100mg

(2R,3S)-1-(tert-Butoxycarbonyl)-3-methylazetidine-2-carboxylic acid, 98%, 1g

p-Anisic anhydride, 95.0%, 25g

Ethyl 2,8-dimethylimidazo[1,2-a]pyridine-3-carboxylate, 95%, 5g

3-Bromobenzenesulfonyl Chloride>98.0%(GC)(T)5g